Harald Herrmann

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations

Life Sciences, Molecular Biology, Molecular Genetics +9

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Harald Herrmann, Irina Sadovnik, Sabine Cerny‐Reiterer et al. · Blood · 2014 · 216 citations · Full text

Medicine, Hematology, Oncology +13

High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia

Wolfgang Warsch, Karoline Kollmann, Eva Eckelhart et al. · Blood · 2011 · 188 citations · Full text

Medicine, Cancer Biology, Molecular Biology +8

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)

Harald Herrmann, Katharina Blatt, Junwei Shi et al. · Oncotarget · 2012 · 154 citations · Full text

Medicine, Hematology, Oncology +16

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Christian Sillaber, Harald Herrmann, Keiryn L. Bennett et al. · European Journal of Clinical Investigation · 2009 · 105 citations

Pharmacy, Pharmacology, Pharmacotherapy +12